# Cytisine for Smoking Cessation

> **NCT05729243** · PHASE4 · COMPLETED · sponsor: **Centre for Addiction and Mental Health** · enrollment: 20 (actual)

## Conditions studied

- Tobacco Use Disorder
- Alcohol Use Disorder
- Smoking Cessation

## Interventions

- **DRUG:** Cytisine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05729243
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-08
- **Primary completion:** 2025-12-12
- **Final completion:** 2025-12-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05729243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05729243, "Cytisine for Smoking Cessation". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT05729243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*